Biotechnology

Amgen Said Drug Reduced Fractures in Older Women (New York Times)

26 Jul 2008

The biotechnology company reported a successful trial for an experimental osteoporosis drug, which reduced the risk of bone fractures in post-menopausal women.

Amgen's osteoporosis drug meets study goal (AP via Yahoo! Finance)

26 Jul 2008

Biotechnology company Amgen Inc. said Friday its osteoporosis drug reduced the incidence of fractured vertebrae in postmenopausal women, meeting a late-stage study goal and driving shares higher in after-hours trading.

Sugar Cane Ethanol Renewable Energy Service and Technology Company, Industrial Biotechnology Corporation Announces ... (Centre Daily Times)

25 Jul 2008

Industrial Biotechnology Corporation, (IBC) (Pink Sheets:IBOT), a service and technology products company utilizing renewable sugar cane ethanol as an alternative to petroleum, is pleased to announce the launch of a new corporate website at www.industrialbiotechnology.com.